Aetna Inc. (NYSE:AET) – Stock analysts at Oppenheimer Holdings dropped their Q4 2017 earnings estimates for shares of Aetna in a research note issued on Thursday. Oppenheimer Holdings analyst M. Wiederhorn now anticipates that the company will earn $1.31 per share for the quarter, down from their prior forecast of $1.66.
Other equities research analysts have also recently issued research reports about the company. UBS AG reaffirmed a “buy” rating and set a $160.00 target price (up previously from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Argus reaffirmed a “buy” rating and set a $165.00 target price (up previously from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. Credit Suisse Group reaffirmed a “buy” rating and set a $155.00 target price on shares of Aetna in a research report on Wednesday, May 17th. Deutsche Bank AG upped their target price on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday. Finally, Cleveland Research raised Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Eight analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Aetna has an average rating of “Buy” and an average price target of $155.78.
ILLEGAL ACTIVITY WARNING: “Q4 2017 Earnings Forecast for Aetna Inc. (AET) Issued By Oppenheimer Holdings” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.com-unik.info/2017/08/19/q4-2017-earnings-forecast-for-aetna-inc-aet-issued-by-oppenheimer-holdings-updated.html.
Aetna (AET) traded down 0.10% during mid-day trading on Monday, hitting $156.83. 152,778 shares of the stock were exchanged. The company has a 50 day moving average price of $153.22 and a 200 day moving average price of $137.42. The stock has a market cap of $52.02 billion, a price-to-earnings ratio of 47.83 and a beta of 0.54. Aetna has a 52 week low of $104.59 and a 52 week high of $157.55.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The company had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The business’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.21 earnings per share.
Hedge funds have recently made changes to their positions in the company. Parametrica Management Ltd acquired a new stake in shares of Aetna during the first quarter valued at approximately $212,000. Private Trust Co. NA acquired a new stake in shares of Aetna during the first quarter valued at approximately $744,000. Schneider Downs Wealth Management Advisors LP acquired a new stake in shares of Aetna during the first quarter valued at approximately $1,797,000. Horan Capital Management acquired a new stake in shares of Aetna during the first quarter valued at approximately $157,000. Finally, TNB Financial acquired a new stake in shares of Aetna during the first quarter valued at approximately $584,000. Institutional investors own 91.73% of the company’s stock.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total value of $14,578,382.13. Following the transaction, the chairman now owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Thursday, July 13th were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, July 11th. This represents a $2.00 annualized dividend and a yield of 1.27%. Aetna’s dividend payout ratio is currently 43.67%.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.